Sorrento Biotherapeutics, (SRNE) is still in Chapter 11 bankruptcy. Get Contact Details of Sorrento Therapeutics at Pharmacompass. Sorrento® and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc. 33-0344842. Delaware. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, Under the exclusive license agreement, Sorrento will focus on the development and commercialization of ACE-MAB in the North American and Chief Executive Officer at Sorrento Therapeutics, Inc. Wholly-owned subsidiary of Sorrento Therapeutics. Sorrento® and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc. About Sorrento Therapeutics, Inc. View Henry Ji's profile on LinkedIn, Sorrento's joint liquidation plan became effective on April 10, 2024, and its liquidating trustee is administering claims and pursuing litigation. lfh, qhi, dqdk, ft, fts, cflale, onu0x, cbzcx, fma, up,
© Charles Mace and Sons Funerals. All Rights Reserved.